Pillstats
Rx only · Aerosol, Foam · Topical

Betamethasone Valerate

Betamethasone Valerate

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1514
US makers3 labelers
Packages8
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.234$0.468$0.701$0.935Dec 2025Apr 2026Jul 2026
$0.703
Latest avg · Jul 22, 2026
-14%
Since Dec 17, 2025
3
Active US suppliers
75%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1873745617492025 Q12025 Q22025 Q32025 Q42026 Q1
410
Rx · 2026 Q1
34K
Units dispensed
-31%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown4SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown2SUPPLYING
Padagis Israel Pharmaceuticals Ltdunknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.